https://www.medxy.ai/news/nationwide-multimodal-prehabilitation-significantly-reduces-complications-after-colorectal-cancer-surgery 2026-07-13T13:01:50.000Z daily 0.75 https://www.medxy.ai/news/vi/nationwide-multimodal-prehabilitation-reduces-complications-after-colorectal-cancer-surgery 2026-07-13T13:14:25.000Z daily 0.75 https://www.medxy.ai/news/ja/nationwide-multimodal-prehabilitation-reduces-complications-in-colorectal-cancer-surgery 2026-07-13T13:14:14.000Z daily 0.75 https://www.medxy.ai/news/optimizing-prognostic-accuracy-in-duodenal-adenocarcinoma-evaluating-lymph-node-staging-schemes 2026-07-13T13:13:54.000Z daily 0.75 https://www.medxy.ai/news/clinical-and-polysomnographic-characteristics-distinguishing-extreme-from-very-severe-pediatric-obstructive-sleep-apnea 2026-07-13T13:13:12.000Z daily 0.75 https://www.medxy.ai/news/vi/clinical-and-polysomnographic-characteristics-in-very-severe-pediatric-obstructive-sleep-apnea 2026-07-13T13:19:30.000Z daily 0.75 https://www.medxy.ai/news/ja/clinical-and-polysomnographic-characteristics-in-pediatric-obstructive-sleep-apnea 2026-07-13T13:20:14.000Z daily 0.75 https://www.medxy.ai/news/zh/polysomnographic-characteristics-in-pediatric-obstructive-sleep-apnea 2026-07-13T13:20:36.000Z daily 0.75 https://www.medxy.ai/news/hypoglossal-nerve-stimulation-significantly-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients-insights-from-the-star-trial 2026-07-13T13:15:54.000Z daily 0.75 https://www.medxy.ai/news/vi/hypoglossal-nerve-stimulation-significantly-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients 2026-07-13T13:22:45.000Z daily 0.75 https://www.medxy.ai/news/ja/hypoglossal-nerve-stimulation-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients 2026-07-13T13:22:37.000Z daily 0.75 https://www.medxy.ai/news/zh/hypoglossal-nerve-stimulation-lowers-obstructive-sleep-apnea-patients 2026-07-13T13:22:30.000Z daily 0.75 https://www.medxy.ai/news/vi/visual-electrophysiology-in-glaucoma 2026-07-13T13:24:27.000Z daily 0.75 https://www.medxy.ai/news/zh/visual-electrophysiology-in-glaucoma-2 2026-07-13T13:25:40.000Z daily 0.75 https://www.medxy.ai/news/vi/visual-electrophysiology-in-glaucoma-3 2026-07-13T13:26:53.000Z daily 0.75 https://www.medxy.ai/news/ja/visual-electrophysiology-in-glaucoma-4 2026-07-13T13:26:48.000Z daily 0.75 https://www.medxy.ai/news/distinct-ocular-symptom-trajectories-after-refractive-surgery 2026-07-13T13:35:51.000Z daily 0.75 https://www.medxy.ai/news/vi/ocular-symptom-trajectories-after-refractive-surgery 2026-07-13T13:36:02.000Z daily 0.75 https://www.medxy.ai/news/tomographic-predictors-of-foveal-versus-extrafoveal-atrophy-onset-in-intermediate-age-related-macular-degeneration 2026-07-13T13:36:32.000Z daily 0.75 https://www.medxy.ai/news/vi/tomographic-predictors-of-atrophy-onset-in-intermediate-age-related-macular-degeneration 2026-07-13T13:36:57.000Z daily 0.75 https://www.medxy.ai/news/ja/tomographic-predictors-of-foveal-versus-extrafoveal-atrophy-onset-in-age-related-macular-degeneration 2026-07-13T13:37:20.000Z daily 0.75 https://www.medxy.ai/news/unlocking-lung-repair-prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway 2026-07-13T13:35:32.000Z daily 0.75 https://www.medxy.ai/news/vi/prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway 2026-07-13T13:38:15.000Z daily 0.75 https://www.medxy.ai/news/ja/prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway-for-lung-repair 2026-07-13T13:39:01.000Z daily 0.75 https://www.medxy.ai/news/zh/prostaglandin-i2-receptor-jun-p53-pathway-drives-alveolar-regeneration-for-lung-repair 2026-07-13T13:39:40.000Z daily 0.75 https://www.medxy.ai/news/cardiac-alterations-in-swimming-induced-pulmonary-edema 2026-07-13T13:40:07.000Z daily 0.75 https://www.medxy.ai/news/vi/cardiac-alterations-in-swimming-induced-pulmonary-edema-2 2026-07-13T13:40:53.000Z daily 0.75 https://www.medxy.ai/news/ja/cardiac-alterations-in-swimming-induced-pulmonary-edema-3 2026-07-13T13:40:58.000Z daily 0.75 https://www.medxy.ai/news/zh/cardiac-alterations-in-swimming-induced-pulmonary-edema-4 2026-07-13T13:41:12.000Z daily 0.75 https://www.medxy.ai/news/pavurutamab-a-bcma-targeting-bispecific-t-cell-engager-promising-phase-1-1b-results-in-triple-class-relapsed-refractory-multiple-myeloma 2026-07-13T13:39:56.000Z daily 0.75 https://www.medxy.ai/news/vi/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma 2026-07-13T13:42:32.000Z daily 0.75 https://www.medxy.ai/news/ja/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma-2 2026-07-13T13:42:22.000Z daily 0.75 https://www.medxy.ai/news/zh/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma-3 2026-07-13T13:42:55.000Z daily 0.75 https://www.medxy.ai/news/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia-clinical-advances-and-future-perspectives 2026-07-13T13:43:08.000Z daily 0.75 https://www.medxy.ai/news/vi/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia 2026-07-13T13:58:06.000Z daily 0.75 https://www.medxy.ai/news/ja/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-acute-myeloid-leukemia 2026-07-13T13:58:29.000Z daily 0.75 https://www.medxy.ai/news/zh/cd7-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia 2026-07-13T13:58:43.000Z daily 0.75 https://www.medxy.ai/news/early-software-assisted-evaluation-enhances-prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients 2026-07-13T13:57:17.000Z daily 0.75 https://www.medxy.ai/news/vi/prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients 2026-07-13T13:59:11.000Z daily 0.75 https://www.medxy.ai/news/physical-restraint-use-in-mechanically-ventilated-icu-patients-impact-on-delirium-and-coma-free-days-over-14-days 2026-07-14T07:32:01.000Z daily 0.75 https://www.medxy.ai/news/vi/physical-restraint-use-in-mechanically-ventilated-icu-patients 2026-07-14T07:31:54.000Z daily 0.75 https://www.medxy.ai/news/ja/physical-restraint-use-in-mechanically-ventilated-icu-patients-free-days-over-14-days 2026-07-14T07:32:14.000Z daily 0.75 https://www.medxy.ai/news/zh/physical-restraint-use-in-mechanically-ventilated-icu-patients-impact-on-delirium-and-coma 2026-07-14T07:32:32.000Z daily 0.75 https://www.medxy.ai/news/enhancing-suicide-prevention-teen-and-caregiver-views-on-lethal-means-safety-planning-in-the-emergency-department 2026-07-14T08:19:45.000Z daily 0.75 https://www.medxy.ai/news/vi/enhancing-suicide-prevention-teen-and-caregiver-in-the-emergency-department 2026-07-14T08:27:59.000Z daily 0.75 https://www.medxy.ai/news/ja/enhancing-suicide-prevention-of-teen-and-caregiver-in-the-emergency-department 2026-07-14T08:34:34.000Z daily 0.75 https://www.medxy.ai/news/zh/suicide-prevention-of-teen-and-caregiver-in-the-emergency-department 2026-07-14T08:28:48.000Z daily 0.75 https://www.medxy.ai/news/sex-differences-in-critical-care-outcomes 2026-07-14T08:33:02.000Z daily 0.75 https://www.medxy.ai/news/vi/sex-differences-in-critical-care-outcomes-in-india 2026-07-14T08:33:25.000Z daily 0.75 https://www.medxy.ai/news/ja/sex-differences-in-critical-care-outcomes-2 2026-07-14T08:33:54.000Z daily 0.75 https://www.medxy.ai/news/zh/sex-differences-in-critical-care-outcomes-3 2026-07-14T08:34:10.000Z daily 0.75 https://www.medxy.ai/news/comparative-effectiveness-of-dialectical-behavior-therapy-and-schema-therapy-in-borderline-personality-disorder 2026-07-14T08:34:51.000Z daily 0.75 https://www.medxy.ai/news/vi/effectiveness-of-dialectical-behavior-therapy-and-schema-therapy-in-borderline-personality-disorder 2026-07-14T08:38:41.000Z daily 0.75 https://www.medxy.ai/news/evaluating-the-economic-impact-of-enhanced-primary-youth-mental-health-services-insights-from-the-access-open-minds-study 2026-07-14T09:07:54.000Z daily 0.75 https://www.medxy.ai/news/vi/evaluating-the-economic-impact-of-enhanced-primary-youth-mental-health-services 2026-07-14T09:22:08.000Z daily 0.75 https://www.medxy.ai/news/ja/enhanced-primary-youth-mental-health-services 2026-07-14T09:22:25.000Z daily 0.75 https://www.medxy.ai/news/zh/the-economic-impact-of-enhanced-primary-youth-mental-health-services 2026-07-14T09:22:43.000Z daily 0.75 https://www.medxy.ai/news/enhancing-facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures 2026-07-14T09:15:37.000Z daily 0.75 https://www.medxy.ai/news/vi/facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures 2026-07-14T09:23:06.000Z daily 0.75 https://www.medxy.ai/news/ja/facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer 2026-07-14T09:23:36.000Z daily 0.75 https://www.medxy.ai/news/zh/facial-reanimation-outcomes-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures 2026-07-14T09:24:00.000Z daily 0.75 https://www.medxy.ai/news/navigating-patient-misconceptions-about-hyaluronic-acid-fillers-for-optimal-aesthetic-outcomes 2026-07-14T09:35:20.000Z daily 0.75 https://www.medxy.ai/news/vi/navigating-patient-misconceptions-about-hyaluronic-acid-for-optimal-aesthetic-outcomes 2026-07-14T09:35:41.000Z daily 0.75 https://www.medxy.ai/news/ja/navigating-patient-misconceptions-about-hyaluronic-acid-fillers-for-aesthetic-outcomes 2026-07-14T09:36:06.000Z daily 0.75 https://www.medxy.ai/news/zh/misconceptions-about-hyaluronic-acid-fillers-for-optimal-aesthetic-outcomes 2026-07-14T09:36:28.000Z daily 0.75 https://www.medxy.ai/news/exploring-institutional-and-insurance-linked-disparities-in-melanoma-outcomes-insights-from-a-va-and-tertiary-care-cohort-study 2026-07-14T09:36:47.000Z daily 0.75 https://www.medxy.ai/news/vi/exploring-institutional-and-insurance-linked-disparities-in-melanoma-outcomes 2026-07-14T09:57:08.000Z daily 0.75 https://www.medxy.ai/news/ja/institutional-and-insurance-linked-disparities-in-melanoma-outcomes-insights-from-a-va-and-tertiary-care-cohort-study 2026-07-14T09:57:31.000Z daily 0.75 https://www.medxy.ai/news/zh/institutional-and-insurance-linked-disparities-in-melanoma-outcomes 2026-07-14T09:57:51.000Z daily 0.75 https://www.medxy.ai/news/circulating-tumor-dna-outperforms-merkel-cell-polyomavirus-antibodies-for-monitoring-recurrence-in-merkel-cell-carcinoma 2026-07-14T10:28:43.000Z daily 0.75 https://www.medxy.ai/news/vi/ctdna-outperforms-merkel-cell-polyomavirus-antibodies-for-monitoring-recurrence-in-merkel-cell-carcinoma 2026-07-14T10:28:38.000Z daily 0.75 https://www.medxy.ai/news/ja/ctdna-outperforms-merkel-cell-polyomavirus-antibodies-for-recurrence-in-merkel-cell-carcinoma 2026-07-14T10:29:09.000Z daily 0.75 https://www.medxy.ai/news/zh/ctdna-outperforms-for-monitoring-recurrence-in-merkel-cell-carcinoma 2026-07-14T10:29:29.000Z daily 0.75 https://www.medxy.ai/news/evaluating-consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-small-cell-lung-cancer 2026-07-14T12:57:55.000Z daily 0.75 https://www.medxy.ai/news/vi/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-small-cell-lung-cancer 2026-07-14T12:58:13.000Z daily 0.75 https://www.medxy.ai/news/ja/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-sclc 2026-07-14T12:59:00.000Z daily 0.75 https://www.medxy.ai/news/zh/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-es-sclc 2026-07-14T12:59:16.000Z daily 0.75 https://www.medxy.ai/news/microplastic-exposure-and-cardiomyopathy-unveiling-the-gut-heart-axis-mechanism 2026-07-14T12:47:08.000Z daily 0.75 https://www.medxy.ai/news/vi/microplastic-exposure-and-cardiomyopathy-unveiling-the-gut-heart-axis 2026-07-14T12:59:34.000Z daily 0.75 https://www.medxy.ai/news/orbita-cto-trial-evaluating-the-impact-of-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina 2026-07-14T13:02:19.000Z daily 0.75 https://www.medxy.ai/news/vi/orbita-cto-trial-evaluating-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina 2026-07-14T13:04:00.000Z daily 0.75 https://www.medxy.ai/news/ja/orbita-cto%E8%A9%A6%E9%A8%93%EF%BC%9A%E5%AE%89%E5%AE%9A%E7%8B%AD%E5%BF%83%E7%97%87%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E7%97%87%E5%80%99%E6%80%A7%E6%85%A2%E6%80%A7%E5%AE%8C%E5%85%A8%E9%96%89%E5%A1%9E 2026-07-14T13:03:20.000Z daily 0.75 https://www.medxy.ai/news/zh/orbita-cto-evaluating-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina 2026-07-14T13:04:37.000Z daily 0.75 https://www.medxy.ai/news/wine-consumption-mediterranean-diet-and-cardiovascular-risk-in-two-spanish-cohorts 2026-07-14T13:07:10.000Z daily 0.75 https://www.medxy.ai/news/vi/wine-consumption-mediterranean-diet-and-cardiovascular-risk 2026-07-14T13:09:04.000Z daily 0.75 https://www.medxy.ai/news/ja/wine-consumption-mediterranean-diet-and-cardiovascular-disease 2026-07-14T13:09:37.000Z daily 0.75 https://www.medxy.ai/news/maternal-diabetes-and-the-elevated-risk-of-early-onset-cardiovascular-disease-in-offspring-insights-from-a-swedish-nationwide-cohort-study 2026-07-14T13:36:06.000Z daily 0.75 https://www.medxy.ai/news/vi/maternal-diabetes-and-the-elevated-risk-of-early-onset-cardiovascular-disease-in-offspring 2026-07-14T14:04:53.000Z daily 0.75 https://www.medxy.ai/news/ja/maternal-diabetes-and-the-risk-of-early-onset-cardiovascular-disease-in-offspring 2026-07-14T14:04:42.000Z daily 0.75 https://www.medxy.ai/news/zh/maternal-diabetes-increase-the-risk-of-early-onset-cardiovascular-disease-in-offspring 2026-07-14T14:04:26.000Z daily 0.75 https://www.medxy.ai/news/herzcheck-revolutionizing-early-detection-of-subclinical-preheart-failure-in-rural-regions-via-mobile-cardiac-mri-and-telemedicine 2026-07-14T14:03:30.000Z daily 0.75 https://www.medxy.ai/news/vi/early-detection-of-subclinical-preheart-failure-in-rural-regions-via-mobile-cardiac-mri-and-telemedicine 2026-07-14T14:05:17.000Z daily 0.75 https://www.medxy.ai/news/exploring-low-dose-antithymocyte-globulin-therapy-in-type-1-diabetes-real-world-insights-using-modified-quantitative-response-of-c-peptide 2026-07-14T14:07:05.000Z daily 0.75 https://www.medxy.ai/news/vi/low-dose-antithymocyte-globulin-therapy-in-type-1-diabetes-real-world-insights-using-modified-quantitative-response-of-c-peptide 2026-07-14T14:08:40.000Z daily 0.75 https://www.medxy.ai/news/next-generation-pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits 2026-07-14T14:08:16.000Z daily 0.75 https://www.medxy.ai/news/vi/next-generation-pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits-2 2026-07-14T14:44:05.000Z daily 0.75 https://www.medxy.ai/news/ja/pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits 2026-07-14T14:44:23.000Z daily 0.75 https://www.medxy.ai/news/zh/next-generation-pharmacotherapies-in-obesity-transforming-care 2026-07-14T14:44:39.000Z daily 0.75 https://www.medxy.ai/news/distinct-immune-subtypes-in-type-1-diabetes-implications-for-disease-progression-and-personalized-immunotherapy 2026-07-14T16:55:44.000Z daily 0.75 https://www.medxy.ai/news/vi/immune-subtypes-in-type-1-diabetes-implications-for-disease-progression-and-personalized-immunotherapy 2026-07-14T16:58:55.000Z daily 0.75 https://www.medxy.ai/news/ja/immune-subtypes-in-type-1-diabetes 2026-07-14T16:59:12.000Z daily 0.75 https://www.medxy.ai/news/zh/immune-subtypes-in-t1dm 2026-07-14T16:59:35.000Z daily 0.75 https://www.medxy.ai/news/acute-neural-biomarker-elevations-after-amateur-soccer-heading-insights-into-potential-brain-injury 2026-07-14T17:05:25.000Z daily 0.75 https://www.medxy.ai/news/vi/acute-neural-biomarker-elevations-after-amateur-soccer-heading 2026-07-14T17:05:19.000Z daily 0.75 https://www.medxy.ai/news/ja/acute-neural-biomarker-after-amateur-soccer-heading 2026-07-14T17:05:52.000Z daily 0.75 https://www.medxy.ai/news/zh/acute-neural-biomarker-elevations-after-amateur-soccer-heading-into-potential-brain-injury 2026-07-14T17:06:19.000Z daily 0.75 https://www.medxy.ai/news/discriminating-prion-diseases-from-alzheimers-disease-using-plasma-biomarkers-the-crucial-role-of-nfl-p-tau217-ratio 2026-07-14T17:03:13.000Z daily 0.75 https://www.medxy.ai/news/vi/discriminating-prion-diseases-from-alzheimers-disease-using-plasma-nfl-p-tau217-ratio 2026-07-14T17:06:47.000Z daily 0.75 https://www.medxy.ai/news/ja/prion-diseases-from-alzheimers-disease-using-plasma-nfl-p-tau217-ratio 2026-07-14T17:07:08.000Z daily 0.75 https://www.medxy.ai/news/zh/prion-diseases-from-alzheimers-disease-by-plasma-nfl-p-tau217-ratio 2026-07-14T17:07:38.000Z daily 0.75 https://www.medxy.ai/news/mad-mt-score-enhancing-patient-selection-for-mechanical-thrombectomy-in-distal-vessel-occlusions 2026-07-14T17:39:06.000Z daily 0.75 https://www.medxy.ai/news/vi/mad-mt-score-enhancing-patient-selection-for-mechanical-thrombectomy-in-distal-vessel-occlusions-2 2026-07-14T17:39:33.000Z daily 0.75 https://www.medxy.ai/news/long-term-risk-of-hepatocellular-carcinoma-after-clearance-of-hepatitis-b-surface-antigen 2026-07-14T21:52:42.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-risk-of-hepatocellular-carcinoma-after-clearance-of-hbs-antigen 2026-07-14T21:56:03.000Z daily 0.75 https://www.medxy.ai/news/ja/longterm-risk-of-hepatocellular-carcinoma-after-clearance-of-hbs-antigen 2026-07-14T21:55:54.000Z daily 0.75 https://www.medxy.ai/news/reclassifying-pediatric-nafld-insights-from-the-steatotic-liver-disease-framework-in-a-multicenter-nash-crn-study 2026-07-15T08:22:07.000Z daily 0.75 https://www.medxy.ai/news/vi/reclassifying-pediatric-nafld-insights-from-the-steatotic-liver-disease-framework 2026-07-15T08:22:29.000Z daily 0.75 https://www.medxy.ai/news/ja/reclassifying-pediatric-nafld-from-the-steatotic-liver-disease-framework 2026-07-15T08:25:42.000Z daily 0.75 https://www.medxy.ai/news/zh/reclassifying-pediatric-nafld-by-the-steatotic-liver-disease-framework 2026-07-15T08:25:17.000Z daily 0.75 https://www.medxy.ai/news/unraveling-fibroblast-diversity-in-vaginal-wall-prolapse-insights-from-single-nucleus-transcriptomics 2026-07-15T08:24:01.000Z daily 0.75 https://www.medxy.ai/news/vi/unraveling-fibroblast-diversity-in-vaginal-wall-prolapse 2026-07-15T08:26:03.000Z daily 0.75 https://www.medxy.ai/news/ja/fibroblast-diversity-in-vaginal-wall-prolapse-insights-from-single-nucleus-transcriptomics 2026-07-15T08:26:20.000Z daily 0.75 https://www.medxy.ai/news/zh/fibroblast-diversity-in-vaginal-wall-prolapse-from-single-nucleus-transcriptomics 2026-07-15T08:26:33.000Z daily 0.75 https://www.medxy.ai/news/severe-lead-poisoning-during-pregnancy-insights-from-a-19-year-nyc-observational-study 2026-07-15T08:27:18.000Z daily 0.75 https://www.medxy.ai/news/vi/severe-lead-poisoning-during-pregnancy-from-a-19-year-observational-study 2026-07-15T09:09:25.000Z daily 0.75 https://www.medxy.ai/news/ja/severe-lead-poisoning-during-pregnancy-from-a-19-year-study 2026-07-15T09:09:59.000Z daily 0.75 https://www.medxy.ai/news/zh/severe-lead-poisoning-during-pregnancy 2026-07-15T09:10:08.000Z daily 0.75 https://www.medxy.ai/news/harnessing-hrd-testing-and-myc-amplification-to-optimize-parp-inhibitor-use-in-brca-wild-type-high-grade-serous-ovarian-carcinoma 2026-07-15T08:58:18.000Z daily 0.75 https://www.medxy.ai/news/vi/harnessing-hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-high-grade-serous-ovarian-carcinoma 2026-07-15T09:10:43.000Z daily 0.75 https://www.medxy.ai/news/ja/hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-ovarian-carcinoma 2026-07-15T09:11:15.000Z daily 0.75 https://www.medxy.ai/news/zh/hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-ovarian-carcinoma-2 2026-07-15T09:11:32.000Z daily 0.75 https://www.medxy.ai/news/endobarrier-duodenal-jejunal-bypass-liner-a-novel-endoscopic-adjunct-for-improved-glycemic-control-and-weight-loss-in-type-2-diabetes-with-obesity 2026-07-15T09:06:44.000Z daily 0.75 https://www.medxy.ai/news/vi/endobarrier-duodenal-jejunal-bypass-liner-a-novel-endoscopic-adjunct-for-improved-glycemic-control-and-weight-loss-in-t2dm 2026-07-15T09:12:08.000Z daily 0.75 https://www.medxy.ai/news/ja/endobarrier-duodenal-jejunal-bypass-liner-for-improved-glycemic-control-and-weight-loss-in-t2dm 2026-07-15T09:14:08.000Z daily 0.75 https://www.medxy.ai/news/zh/endobarrier-duodenal-jejunal-bypass-liner-for-glycemic-control-and-weight-loss-in-t2dm 2026-07-15T09:14:29.000Z daily 0.75 https://www.medxy.ai/news/enhancing-intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging-insights-from-the-brima-trial 2026-07-15T09:08:56.000Z daily 0.75 https://www.medxy.ai/news/vi/enhancing-intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging 2026-07-15T09:15:09.000Z daily 0.75 https://www.medxy.ai/news/ja/intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging 2026-07-15T09:15:28.000Z daily 0.75 https://www.medxy.ai/news/zh/intraoperative-margin-assessment-in-early-stage-breast-cancer-with-pet-ct-imaging 2026-07-15T09:15:44.000Z daily 0.75 https://www.medxy.ai/news/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd-undergoing-liver-transplantation-and-colectomy-insights-from-a-multicenter-study 2026-07-15T09:14:41.000Z daily 0.75 https://www.medxy.ai/news/vi/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd-undergoing-liver-transplantation-and-colectomy 2026-07-15T09:16:44.000Z daily 0.75 https://www.medxy.ai/news/ja/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd 2026-07-15T09:17:48.000Z daily 0.75 https://www.medxy.ai/news/zh/outcomes-of-colorectal-dysplasia-and-cancer-in-psc-ibd-liver-transplantation-and-colectomy 2026-07-15T09:17:39.000Z daily 0.75 https://www.medxy.ai/news/efficacy-of-recurrent-laryngeal-nerve-reinnervation-in-pediatric-unilateral-vocal-fold-paralysis-insights-from-a-largest-single-center-series 2026-07-15T09:18:08.000Z daily 0.75 https://www.medxy.ai/news/vi/efficacy-of-recurrent-laryngeal-nerve-reinnervation-in-pediatric-unilateral-vocal-fold-paralysis 2026-07-15T09:28:21.000Z daily 0.75 https://www.medxy.ai/news/ja/recurrent-laryngeal-nerve-reinnervation-in-pediatric-unilateral-vocal-fold-paralysis 2026-07-15T09:28:13.000Z daily 0.75 https://www.medxy.ai/news/bridging-subjective-symptoms-and-objective-imaging-in-chronic-rhinosinusitis-impact-of-an-adaptive-sino-nasal-outcome-test 2026-07-15T09:27:39.000Z daily 0.75 https://www.medxy.ai/news/vi/bridging-subjective-symptoms-and-objective-imaging-in-chronic-rhinosinusitis 2026-07-15T09:52:53.000Z daily 0.75 https://www.medxy.ai/news/a-consensus-reference-standard-for-ai-screening-of-age-related-macular-degeneration-what-clinicians-and-developers-need-to-know 2026-07-15T09:33:52.000Z daily 0.75 https://www.medxy.ai/news/zh/a-consensus-reference-standard-for-ai-screening-of-age-related-macular-degeneration 2026-07-15T09:53:16.000Z daily 0.75 https://www.medxy.ai/news/vi/a-consensus-standard-for-ai-screening-of-age-related-macular-degeneration 2026-07-15T09:53:34.000Z daily 0.75 https://www.medxy.ai/news/ja/a-consensus-for-ai-screening-of-age-related-macular-degeneration 2026-07-15T09:53:51.000Z daily 0.75 https://www.medxy.ai/news/artificial-intelligence-smart-eyeglasses-for-the-detection-and-description-of-stationary-objects-a-pilot-feasibility-study 2026-07-15T09:37:49.000Z daily 0.75 https://www.medxy.ai/news/hyperreflective-abnormal-areas-in-middle-retinal-layers-via-en-face-oct-a-novel-biomarker-for-diabetic-retinopathy-risk-stratification 2026-07-15T09:51:47.000Z daily 0.75 https://www.medxy.ai/news/vi/hyperreflective-abnormal-areas-in-middle-retinal-layers 2026-07-15T10:06:02.000Z daily 0.75 https://www.medxy.ai/news/ja/hyperreflective-abnormal-areas-in-middle-retinal-layers-via-en-face-oct-for-diabetic-retinopathy-risk-stratification 2026-07-15T10:06:28.000Z daily 0.75 https://www.medxy.ai/news/zh/hyperreflective-abnormal-areas-in-middle-retinal-layers-via-en-face-oct-for-diabetic-retinopathy-risk 2026-07-15T10:06:53.000Z daily 0.75 https://www.medxy.ai/news/mosaic-loss-of-y-chromosome-links-to-pulmonary-decline-emphysema-and-accelerated-epigenetic-aging-in-men-a-comprehensive-review 2026-07-15T10:10:14.000Z daily 0.75 https://www.medxy.ai/news/vi/mosaic-loss-of-y-chromosome-links-to-pulmonary-decline-emphysema-and-accelerated-epigenetic-aging-in-men 2026-07-15T10:10:24.000Z daily 0.75 https://www.medxy.ai/news/ja/loss-of-y-chromosome-links-to-pulmonary-decline-and-epigenetic-aging-in-men 2026-07-15T10:11:27.000Z daily 0.75 https://www.medxy.ai/news/zh/loss-of-y-chromosome-to-pulmonary-decline-and-epigenetic-aging-in-men 2026-07-15T10:11:41.000Z daily 0.75 https://www.medxy.ai/news/harnessing-precision-medicine-the-aps-consortiums-national-platform-for-phenotyping-ards-pneumonia-and-sepsis 2026-07-15T10:11:44.000Z daily 0.75 https://www.medxy.ai/news/flt3-itd-signaling-drives-immune-evasion 2026-07-15T12:39:18.000Z daily 0.75 https://www.medxy.ai/news/vi/flt3-itd-signaling-drives-immune-evasion-via-pkc-stat1 2026-07-15T12:39:38.000Z daily 0.75 https://www.medxy.ai/news/molecular-mutations-and-cardiovascular-risks-shape-prognosis-in-triple-negative-essential-thrombocythemia 2026-07-15T12:32:13.000Z daily 0.75 https://www.medxy.ai/news/vi/molecular-mutations-and-cardiovascular-risks-shape-prognosis-in-triple-negative-essential-thrombocythemia-2 2026-07-15T12:40:32.000Z daily 0.75 https://www.medxy.ai/news/ja/molecular-mutations-and-cardiovascular-risks-impact-prognosis-in-triple-negative-essential-thrombocythemia 2026-07-15T12:40:58.000Z daily 0.75 https://www.medxy.ai/news/zh/molecular-mutations-and-cardiovascular-risks-shape-prognosis-in-triple-negative-essential-thrombocythemia-3 2026-07-15T12:41:30.000Z daily 0.75 https://www.medxy.ai/news/navigating-dual-resistance-in-extranodal-nk-t-cell-lymphoma-challenges-and-emerging-insights 2026-07-15T12:37:23.000Z daily 0.75 https://www.medxy.ai/news/vi/navigating-dual-resistance-in-extranodal-nk-t-cell-lymphoma 2026-07-15T15:23:21.000Z daily 0.75 https://www.medxy.ai/news/ja/dual-resistance-in-extranodal-nk-t-cell-lymphoma 2026-07-15T15:23:31.000Z daily 0.75 https://www.medxy.ai/news/zh/dual-resistance-in-extranodal-nkt-cell-lymphoma 2026-07-15T15:23:42.000Z daily 0.75 https://www.medxy.ai/news/hypoxia-induced-bach1-elevation-drives-pulmonary-hypertension-via-activation-of-tgfbr2-smad-signaling 2026-07-15T22:14:17.000Z daily 0.75 https://www.medxy.ai/news/vi/hypoxia-induced-bach1-elevation-drives-pulmonary-hypertension-via-tgfbr2-smad-signaling 2026-07-15T22:36:53.000Z daily 0.75 https://www.medxy.ai/news/ja/hypoxia-induced-bach1-elevation-drives-pulmonary-hypertension-via-activation-of-tgfbr2-smad-signaling-2 2026-07-15T22:36:42.000Z daily 0.75 https://www.medxy.ai/news/zh/hypoxia-induced-bach1-elevation-drives-pulmonary-hypertension-via-activation-of-tgfbr2-smad-signaling-3 2026-07-15T22:36:32.000Z daily 0.75 https://www.medxy.ai/news/coronary-artery-calcium-and-statin-allocation-in-the-era-of-prevent-evidence-from-mesa 2026-07-16T07:17:27.000Z daily 0.75 https://www.medxy.ai/news/vi/coronary-artery-calcium-and-statin-allocation-in-the-era-of-prevent 2026-07-16T07:15:05.000Z daily 0.75 https://www.medxy.ai/news/zh/coronary-artery-calcium-and-statin-allocation 2026-07-16T07:16:29.000Z daily 0.75 https://www.medxy.ai/news/temporal-trends-in-oral-anticoagulant-use-and-clinical-outcomes-among-older-adults-with-atrial-fibrillation 2026-07-16T07:17:50.000Z daily 0.75 https://www.medxy.ai/news/vi/trends-in-oral-anticoagulant-use-and-clinical-outcomes-among-older-adults-with-atrial-fibrillation 2026-07-16T07:18:46.000Z daily 0.75 https://www.medxy.ai/news/ja/trends-in-oral-anticoagulant-use-and-clinical-outcomes-with-atrial-fibrillation 2026-07-16T07:19:08.000Z daily 0.75 https://www.medxy.ai/news/zh/trends-in-oral-anticoagulant-use-and-outcomes-with-atrial-fibrillation 2026-07-16T07:20:46.000Z daily 0.75 https://www.medxy.ai/news/non-hdl-cholesterol-and-apolipoprotein-b-measures-and-risk-of-atherosclerotic-cardiovascular-disease 2026-07-16T07:20:30.000Z daily 0.75 https://www.medxy.ai/news/vi/non-hdl-c-and-apolipoprotein-b-measures-and-risk-of-atherosclerotic-cardiovascular-disease 2026-07-16T07:23:25.000Z daily 0.75 https://www.medxy.ai/news/bridging-the-gap-improving-skilled-nursing-facility-to-home-transitions-for-heart-failure-patients 2026-07-16T07:23:45.000Z daily 0.75 https://www.medxy.ai/news/vi/skilled-nursing-facility-to-home-transitions-for-heart-failure-patients 2026-07-16T08:23:55.000Z daily 0.75 https://www.medxy.ai/news/ja/improving-skilled-nursing-facility-to-home-transitions-for-heart-failure-patients 2026-07-16T08:24:14.000Z daily 0.75 https://www.medxy.ai/news/zh/the-gap-improving-skilled-nursing-facility-to-home-transitions-for-heart-failure-patients 2026-07-16T08:25:02.000Z daily 0.75 https://www.medxy.ai/news/efficacy-and-safety-of-osilodrostat-in-adrenal-cushing-syndrome-insights-from-an-international-real-world-study 2026-07-16T08:34:34.000Z daily 0.75 https://www.medxy.ai/news/vi/efficacy-and-safety-of-osilodrostat-in-adrenal-cushing-syndrome 2026-07-16T08:36:25.000Z daily 0.75 https://www.medxy.ai/news/ja/osilodrostat-in-adrenal-cushing-syndrome 2026-07-16T08:36:44.000Z daily 0.75 https://www.medxy.ai/news/zh/osilodrostat-for-adrenal-cushing-syndrome 2026-07-16T09:08:57.000Z daily 0.75 https://www.medxy.ai/news/interleukin-6-receptor-blockade-a-promising-strategy-for-relapse-prevention-in-mog-antibody-associated-disease 2026-07-16T09:08:08.000Z daily 0.75 https://www.medxy.ai/news/vi/interleukin-6-receptor-blockade-for-relapse-prevention-in-mog-antibody-associated-disease 2026-07-16T09:16:38.000Z daily 0.75 https://www.medxy.ai/news/ja/interleukin-6-receptor-blockade-for-relapse-in-mog-antibody-associated-disease 2026-07-16T09:17:14.000Z daily 0.75 https://www.medxy.ai/news/zh/interleukin-6-receptor-blockade-for-mog-antibody-associated-disease 2026-07-16T09:17:32.000Z daily 0.75 https://www.medxy.ai/news/sustained-upper-limb-recovery-with-paired-vagus-nerve-stimulation-two-years-post-stroke-insights-from-the-vns-rehab-trial 2026-07-16T09:16:14.000Z daily 0.75 https://www.medxy.ai/news/vi/sustained-upper-limb-recovery-with-paired-vagus-nerve-stimulation-two-years-post-stroke 2026-07-16T09:18:00.000Z daily 0.75 https://www.medxy.ai/news/ja/sustained-upper-limb-recovery-with-paired-vagus-nerve-stimulation-post-stroke 2026-07-16T09:18:22.000Z daily 0.75 https://www.medxy.ai/news/zh/%E9%85%8D%E5%AF%B9%E8%BF%B7%E8%B5%B0%E7%A5%9E%E7%BB%8F%E5%88%BA%E6%BF%80%E5%8A%A9%E5%8A%9B%E5%8D%92%E4%B8%AD%E5%90%8E%E4%B8%8A%E8%82%A2%E5%8A%9F%E8%83%BD%E6%8C%81%E4%B9%85%E6%81%A2%E5%A4%8D%EF%BC%9Avn 2026-07-16T09:17:43.000Z daily 0.75 https://www.medxy.ai/news/optical-ministroke-in-the-mediodorsal-thalamus-reveals-critical-links-between-sleep-oscillations-and-memory-restoration 2026-07-16T09:56:12.000Z daily 0.75 https://www.medxy.ai/news/vi/optical-ministroke-in-the-mediodorsal-thalamus-links-between-sleep-oscillations-and-memory-restoration 2026-07-16T10:07:30.000Z daily 0.75 https://www.medxy.ai/news/ja/optical-ministroke-in-the-mediodorsal-thalamus-links-sleep-oscillations-and-memory-restoration 2026-07-16T10:07:46.000Z daily 0.75 https://www.medxy.ai/news/zh/optical-ministroke-in-the-mediodorsal-thalamus-links-sleep-and-memory-restoration 2026-07-16T10:08:12.000Z daily 0.75 https://www.medxy.ai/news/targeting-sox9-driven-spem-plasticity-a-new-therapeutic-avenue-to-prevent-gastric-cancer-progression 2026-07-16T10:08:33.000Z daily 0.75 https://www.medxy.ai/news/vi/sox9-driven-spem-plasticity-a-new-therapeutic-avenue-to-prevent-gastric-cancer-progression 2026-07-16T10:22:36.000Z daily 0.75 https://www.medxy.ai/news/ja/sox9-driven-spem-plasticity-to-prevent-gastric-cancer-progression 2026-07-16T10:23:00.000Z daily 0.75 https://www.medxy.ai/news/zh/sox9-driven-spem-plasticity-to-prevent-gastric-cancer 2026-07-16T10:23:17.000Z daily 0.75 https://www.medxy.ai/news/multimodal-c9-66-car-t-cell-therapy-a-promising-advance-in-pancreatic-cancer-treatment 2026-07-16T10:17:13.000Z daily 0.75 https://www.medxy.ai/news/vi/multimodal-c9-66-car-t-cell-therapy-a-promising-advance-in-pancreatic-cancer 2026-07-16T10:23:35.000Z daily 0.75 https://www.medxy.ai/news/ja/c9-66-car-t-cell-therapy-a-promising-advance-in-pancreatic-cancer-treatment 2026-07-16T10:23:52.000Z daily 0.75 https://www.medxy.ai/news/zh/multimodal-c9-66-car-t-cell-therapy-advance-in-pancreatic-cancer-treatment 2026-07-16T10:24:07.000Z daily 0.75 https://www.medxy.ai/news/global-variability-in-non-invasive-testing-accuracy-for-masld-key-findings-from-the-g-masld-study 2026-07-16T10:22:21.000Z daily 0.75 https://www.medxy.ai/news/vi/global-variability-in-non-invasive-testing-accuracy-for-masld 2026-07-16T10:24:49.000Z daily 0.75 https://www.medxy.ai/news/ja/variability-in-non-invasive-testing-accuracy-for-masld 2026-07-16T10:25:10.000Z daily 0.75 https://www.medxy.ai/news/zh/non-invasive-testing-accuracy-for-masld 2026-07-16T10:25:33.000Z daily 0.75 https://www.medxy.ai/news/accuracy-of-menstrual-history-in-assessing-gestational-age-among-adolescents-seeking-abortion-in-england-and-wales 2026-07-16T10:24:29.000Z daily 0.75 https://www.medxy.ai/news/decade-long-outcomes-of-surgical-options-in-rectal-endometriosis-insights-from-a-robust-randomized-trial 2026-07-16T10:28:47.000Z daily 0.75 https://www.medxy.ai/news/vi/decade-long-outcomes-of-surgical-options-in-rectal-endometriosis 2026-07-16T10:30:28.000Z daily 0.75 https://www.medxy.ai/news/ja/long-outcomes-of-surgical-options-in-rectal-endometriosis 2026-07-16T10:31:30.000Z daily 0.75 https://www.medxy.ai/news/zh/outcomes-of-surgical-options-in-rectal-endometriosis 2026-07-16T10:31:22.000Z daily 0.75 https://www.medxy.ai/news/impaired-hearing-and-elevated-systolic-blood-pressure-clinical-markers-for-silent-cerebral-infarcts-following-eclampsia 2026-07-16T14:18:50.000Z daily 0.75 https://www.medxy.ai/news/vi/impaired-hearing-and-elevated-systolic-blood-pressure-clinical-markers-for-silent-cerebral-infarcts 2026-07-16T14:20:59.000Z daily 0.75 https://www.medxy.ai/news/ja/impaired-hearing-and-elevated-systolic-blood-pressure-for-silent-cerebral-infarcts 2026-07-16T14:21:25.000Z daily 0.75 https://www.medxy.ai/news/zh/hearing-and-systolic-blood-pressure-for-silent-cerebral-infarcts 2026-07-16T14:21:42.000Z daily 0.75 https://www.medxy.ai/news/balancing-risk-and-quality-of-life-factors-influencing-timing-of-oophorectomy-after-risk-reducing-salpingectomy-in-brca-previvors 2026-07-16T14:23:04.000Z daily 0.75 https://www.medxy.ai/news/vi/risk-and-quality-of-life-factors-influencing-oophorectomy-after-risk-reducing-salpingectomy-in-brca-previvors 2026-07-16T14:23:44.000Z daily 0.75 https://www.medxy.ai/news/ja/brca-previvor%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E5%8D%B5%E5%B7%A3%E6%91%98%E5%87%BA%E3%81%AE%E6%9C%80%E9%81%A9%E6%99%82%E6%9C%9F%E3%82%92%E3%81%A9%E3%81%86%E8%A6%8B%E6%A5%B5%E3%82%81%E3%82%8B 2026-07-16T14:23:02.000Z daily 0.75 https://www.medxy.ai/news/zh/balancing-risk-and-quality-of-life-factors-in-brca-previvors 2026-07-16T14:24:23.000Z daily 0.75 https://www.medxy.ai/news/harnessing-machine-learning-to-predict-patient-reported-outcomes-after-breast-reconstruction-a-step-forward-in-personalized-surgical-care 2026-07-16T14:24:52.000Z daily 0.75 https://www.medxy.ai/news/vi/machine-learning-to-predict-patient-reported-outcomes-after-breast-reconstruction-a-step-forward-in-personalized-surgical-care 2026-07-16T22:41:16.000Z daily 0.75 https://www.medxy.ai/news/ja/machine-learning-for-breast-reconstruction-a-step-forward-in-personalized-surgical-care 2026-07-16T22:41:37.000Z daily 0.75 https://www.medxy.ai/news/zh/machine-learning-for-breast-reconstruction 2026-07-16T22:42:10.000Z daily 0.75 https://www.medxy.ai/news/robotic-versus-laparoscopic-complex-elective-cholecystectomy-balancing-outcomes-and-costs 2026-07-17T07:24:09.000Z daily 0.75 https://www.medxy.ai/news/vi/robotic-versus-laparoscopic-complex-elective-cholecystectomy 2026-07-17T07:26:04.000Z daily 0.75 https://www.medxy.ai/news/ja/robotic-versus-laparoscopic-elective-cholecystectomy 2026-07-17T07:26:44.000Z daily 0.75 https://www.medxy.ai/news/zh/outcomes-and-costs-of-robotic-versus-laparoscopic-complex-elective-cholecystectomy-balancing 2026-07-17T07:27:31.000Z daily 0.75 https://www.medxy.ai/news/timing-matters-optimizing-additional-surgery-after-noncurative-endoscopic-submucosal-dissection-in-early-gastric-cancer 2026-07-17T07:27:20.000Z daily 0.75 https://www.medxy.ai/news/vi/optimizing-additional-surgery-after-noncurative-endoscopic-submucosal-dissection-in-early-gastric-cancer 2026-07-17T08:11:36.000Z daily 0.75 https://www.medxy.ai/news/ja/additional-surgery-after-noncurative-endoscopic-submucosal-dissection-in-early-gastric-cancer 2026-07-17T08:10:36.000Z daily 0.75 https://www.medxy.ai/news/zh/additional-surgery-at-35-day-after-noncurative-endoscopic-submucosal-dissection-in-early-gastric-cancer 2026-07-17T08:11:27.000Z daily 0.75 https://www.medxy.ai/news/histopathological-impact-of-prolonged-intubation-on-the-trachea-implications-for-early-tracheotomy 2026-07-17T08:12:10.000Z daily 0.75 https://www.medxy.ai/news/vi/histopathological-impact-of-prolonged-intubation-on-the-trachea 2026-07-17T13:02:16.000Z daily 0.75 https://www.medxy.ai/news/ja/impact-of-prolonged-intubation-on-the-trachea-implications-for-early-tracheotomy 2026-07-17T13:02:35.000Z daily 0.75 https://www.medxy.ai/news/zh/impact-of-prolonged-intubation-on-the-trachea 2026-07-17T13:02:55.000Z daily 0.75 https://www.medxy.ai/news/validating-the-adaptive-sinonasal-outcome-test-snot-a-clinically-reliable-tool-for-chronic-rhinosinusitis-assessment 2026-07-17T15:39:46.000Z daily 0.75 https://www.medxy.ai/news/vi/snot-a-clinically-reliable-tool-for-chronic-rhinosinusitis-assessment 2026-07-17T13:03:21.000Z daily 0.75 https://www.medxy.ai/news/ja/validating-the-adaptive-sinonasal-outcome-test-for-chronic-rhinosinusitis-assessment 2026-07-17T13:03:42.000Z daily 0.75 https://www.medxy.ai/news/zh/snot-tool-for-chronic-rhinosinusitis-assessment 2026-07-17T13:04:02.000Z daily 0.75 https://www.medxy.ai/news/bridging-the-gap-geographic-disparities-in-access-to-diabetic-retinopathy-care-across-the-united-states 2026-07-17T11:49:56.000Z daily 0.75 https://www.medxy.ai/news/outcomes-of-nasal-vertical-rectus-belly-transposition-and-lateral-rectus-recession-for-large-exotropia-after-medial-rectus-transection-a-case-series 2026-07-17T13:01:48.000Z daily 0.75 https://www.medxy.ai/news/decoding-the-pulmonary-immune-landscape-in-influenza-insights-from-a-large-scale-single-cell-atlas 2026-07-17T13:04:26.000Z daily 0.75 https://www.medxy.ai/news/vi/decoding-the-pulmonary-immune-landscape-in-influenza 2026-07-17T13:07:11.000Z daily 0.75 https://www.medxy.ai/news/ja/the-pulmonary-immune-landscape-in-influenza 2026-07-17T13:07:26.000Z daily 0.75 https://www.medxy.ai/news/evaluating-riociguat-in-early-pulmonary-vascular-disease-insights-from-the-esra-phase-iia-trial 2026-07-17T13:06:47.000Z daily 0.75 https://www.medxy.ai/news/vi/evaluating-riociguat-in-early-pulmonary-vascular-disease 2026-07-17T13:08:43.000Z daily 0.75 https://www.medxy.ai/news/ja/riociguat-in-early-pulmonary-vascular-disease 2026-07-17T13:08:58.000Z daily 0.75 https://www.medxy.ai/news/zh/riociguat-for-early-pulmonary-vascular-disease 2026-07-17T13:09:23.000Z daily 0.75 https://www.medxy.ai/news/unraveling-mdm4-haploinsufficiency-a-novel-tp53-dependent-mechanism-driving-bone-marrow-failure-syndromes 2026-07-17T13:09:51.000Z daily 0.75 https://www.medxy.ai/news/vi/unraveling-mdm4-haploinsufficiency-driving-bone-marrow-failure-syndromes 2026-07-17T13:12:34.000Z daily 0.75 https://www.medxy.ai/news/ja/mdm4-haploinsufficiency-driving-bone-marrow-failure-syndromes 2026-07-17T13:12:52.000Z daily 0.75 https://www.medxy.ai/news/zh/p53-mdm4-driving-bone-marrow-failure-syndromes 2026-07-17T13:13:20.000Z daily 0.75 https://www.medxy.ai/news/eif4a3-driven-nonsense-mediated-decay-a-novel-regulatory-axis-modulating-aml1-eto9a-dosage-and-clinical-outcomes-in-t821-acute-myeloid-leukemia 2026-07-17T13:11:59.000Z daily 0.75 https://www.medxy.ai/news/vi/eif4a3-driven-nonsense-mediated-decay-modulating-aml1-eto9a-dosage-and-clinical-outcomes-in-t821-acute-myeloid-leukemia 2026-07-17T13:13:51.000Z daily 0.75 https://www.medxy.ai/news/ja/eif4a3-driven-nonsense-mediated-decay-in-t821-acute-myeloid-leukemia 2026-07-17T13:14:22.000Z daily 0.75 https://www.medxy.ai/news/glp-1-receptor-agonists-and-the-risk-of-ischemic-optic-neuropathy-in-type-2-diabetes-evidence-from-a-target-trial-emulation 2026-07-17T13:15:15.000Z daily 0.75 https://www.medxy.ai/news/vi/glp-1-receptor-agonists-and-the-risk-of-ischemic-optic-neuropathy-in-type-2-diabetes-evidence-from-a-tte 2026-07-17T13:16:44.000Z daily 0.75 https://www.medxy.ai/news/ja/glp-1-receptor-agonists-and-the-risk-of-ischemic-optic-neuropathy-in-type-2-diabetes 2026-07-17T13:17:02.000Z daily 0.75 https://www.medxy.ai/news/zh/glp-1-receptor-agonists-and-the-risk-of-ischemic-optic-neuropathy-in-t2dm 2026-07-17T13:17:21.000Z daily 0.75 https://www.medxy.ai/news/quality-cost-and-timeliness-of-cancer-treatment-in-medicare-advantage-versus-traditional-medicare-an-evidence-based-review 2026-07-17T14:47:24.000Z daily 0.75 https://www.medxy.ai/news/vi/quality-cost-and-timeliness-of-cancer-treatment-in-medicare-advantage-versus-traditional-medicare 2026-07-17T14:47:16.000Z daily 0.75 https://www.medxy.ai/news/ja/quality-cost-and-timeliness-of-cancer-in-medicare-versus-traditional-medicare 2026-07-17T14:47:48.000Z daily 0.75 https://www.medxy.ai/news/polypharmacy-challenges-in-older-adults-with-metabolic-dysfunction-associated-steatotic-liver-disease-navigating-care-in-a-high-risk-population 2026-07-17T14:41:27.000Z daily 0.75 https://www.medxy.ai/news/unraveling-the-diarrheal-outbreaks-understanding-cyclospora-and-cryptosporidiosis-in-the-united-states 2026-07-17T14:46:43.000Z daily 0.75 https://www.medxy.ai/news/vi/unraveling-the-diarrheal-outbreaks-understanding-cyclospora-and-cryptosporidiosis 2026-07-17T14:48:04.000Z daily 0.75 https://www.medxy.ai/news/ja/unraveling-the-diarrheal-outbreaks-understanding-cyclospora-and-cryptosporidiosis-in-the-usa 2026-07-17T14:48:28.000Z daily 0.75 https://www.medxy.ai/news/hepatitis-c-screening-among-persons-experiencing-homelessness-in-emergency-departments-insights-from-the-detect-hep-c-screening-trial-and-related-evidence 2026-07-17T15:59:45.000Z daily 0.75 https://www.medxy.ai/news/vi/hepatitis-c-screening-among-persons-experiencing-homelessness-in-emergency-departments 2026-07-17T15:59:53.000Z daily 0.75 https://www.medxy.ai/news/early-shenfu-injection-in-sepsis-impact-on-hemodynamics-mortality-and-microcirculation-in-a-multicenter-rct 2026-07-17T16:50:45.000Z daily 0.75 https://www.medxy.ai/news/vi/early-shenfu-injection-in-sepsis-impact-on-hemodynamics-mortality-and-microcirculation 2026-07-17T17:30:11.000Z daily 0.75 https://www.medxy.ai/news/ja/shenfu-injection-in-sepsis 2026-07-17T17:31:08.000Z daily 0.75 https://www.medxy.ai/news/zh/shenfu-injection-for-sepsis 2026-07-17T17:31:26.000Z daily 0.75 https://www.medxy.ai/news/evaluating-high-flow-nasal-cannula-oxygen-use-during-noninvasive-ventilation-breaks-after-extubation-clinical-outcomes-from-a-multicenter-observational-study 2026-07-17T17:29:26.000Z daily 0.75 https://www.medxy.ai/news/vi/evaluating-high-flow-nasal-cannula-oxygen-use-during-noninvasive-ventilation-breaks-after-extubation 2026-07-17T17:32:13.000Z daily 0.75 https://www.medxy.ai/news/lb-102-in-acute-schizophrenia-a-promising-benzamide-antipsychotic-with-demonstrated-efficacy-and-safety 2026-07-17T17:44:55.000Z daily 0.75 https://www.medxy.ai/news/vi/efficacy-and-safety-lb-102-in-acute-schizophrenia-a-benzamide-antipsychotic 2026-07-17T17:41:23.000Z daily 0.75 https://www.medxy.ai/news/ja/efficacy-and-safety-lb-102-in-acute-schizophrenia 2026-07-17T17:41:53.000Z daily 0.75 https://www.medxy.ai/news/zh/efficacy-and-safety-lb-102-for-acute-schizophrenia 2026-07-17T17:41:47.000Z daily 0.75 https://www.medxy.ai/news/differential-brain-lithium-dynamics-in-bipolar-disorder-insights-from-7li-mri-comparing-once-vs-twice-daily-dosing-regimens 2026-07-17T17:46:49.000Z daily 0.75 https://www.medxy.ai/news/vi/differential-brain-lithium-dynamics-in-bipolar-disorder 2026-07-17T17:45:40.000Z daily 0.75 https://www.medxy.ai/news/ja/comparing-once-vs-twice-daily-dosing-regimens-of-differential-brain-lithium-dynamics-in-bipolar-disorder 2026-07-17T17:46:19.000Z daily 0.75 https://www.medxy.ai/news/zh/once-vs-twice-daily-dosing-regimens-of-differential-brain-lithium-dynamics-in-bipolar-disorder 2026-07-17T17:46:37.000Z daily 0.75 https://www.medxy.ai/news/reducing-surgical-site-infection-in-implant-based-breast-reconstruction-clinical-impact-of-the-gaps-protocol-over-five-years 2026-07-18T11:47:01.000Z daily 0.75 https://www.medxy.ai/news/vi/reducing-surgical-site-infection-in-implant-based-breast-reconstruction 2026-07-18T11:55:24.000Z daily 0.75 https://www.medxy.ai/news/zh/surgical-site-infection-in-implant-based-breast-reconstruction 2026-07-18T11:55:46.000Z daily 0.75 https://www.medxy.ai/news/advancing-gender-affirming-surgery-nipple-punch-grafts-combined-with-3d-areola-tattooing-for-superior-aesthetic-outcomes 2026-07-18T11:53:37.000Z daily 0.75 https://www.medxy.ai/news/ja/gender-affirming-surgery-nipple-punch-grafts-combined-with-3d-areola-tattooing 2026-07-18T11:56:32.000Z daily 0.75 https://www.medxy.ai/news/zh/gender-affirming-surgery-nipple-punch-grafts-combined-with-3d-areola-tattooing-for-superior-aesthetic-outcomes 2026-07-18T11:58:18.000Z daily 0.75 https://www.medxy.ai/news/resuscitation-from-out-of-hospital-cardiac-arrest-reliable-association-of-etco2-with-rosc 2026-07-18T11:58:29.000Z daily 0.75 https://www.medxy.ai/news/vi/resuscitation-from-out-of-hospital-cardiac-arrest-of-etco2-with-rosc 2026-07-18T12:01:24.000Z daily 0.75 https://www.medxy.ai/news/ja/out-of-hospital-cardiac-arrest-of-etco2-with-rosc 2026-07-18T12:01:40.000Z daily 0.75 https://www.medxy.ai/news/revolutionizing-myocardial-scar-detection-ai-powered-contrast-free-mri-via-virtual-native-enhancement 2026-07-18T12:00:34.000Z daily 0.75 https://www.medxy.ai/news/vi/myocardial-scar-detection-ai-powered-contrast-free-mri-via-virtual-native-enhancement 2026-07-18T12:02:57.000Z daily 0.75 https://www.medxy.ai/news/ja/myocardial-scar-detection-ai-powered-contrast-free-mri 2026-07-18T12:03:17.000Z daily 0.75 https://www.medxy.ai/news/zh/myocardial-scar-detection-ai-powered-contrast-mri 2026-07-18T12:03:35.000Z daily 0.75 https://www.medxy.ai/news/peripheral-artery-disease-emerging-advances-in-medical-therapy-to-reduce-cardiovascular-and-limb-risks 2026-07-18T19:09:10.000Z daily 0.75 https://www.medxy.ai/news/development-and-validation-of-a-simplified-martin-hopkins-ldl-c-equation-using-machine-learning 2026-07-19T07:57:52.000Z daily 0.75 https://www.medxy.ai/news/vi/development-and-validation-of-a-simplified-martin-hopkins-ldl-c-equation-using-machine-learning-2 2026-07-18T21:44:52.000Z daily 0.75 https://www.medxy.ai/news/ja/development-and-validation-of-a-simplified-martin-hopkins-ldl-c-equation-using-machine-learning-3 2026-07-19T07:58:43.000Z daily 0.75 https://www.medxy.ai/news/igg-n-glycosylation-profiles-as-predictive-biomarkers-for-diabetic-nephropathy-in-type-2-diabetes-insights-from-a-pooled-prospective-cohort-analysis 2026-07-19T08:03:18.000Z daily 0.75 https://www.medxy.ai/news/vi/igg-n-glycosylation-profiles-as-predictive-biomarkers-for-diabetic-nephropathy-in-type-2-diabetes 2026-07-20T07:46:54.000Z daily 0.75 https://www.medxy.ai/news/ja/igg-n-glycosylation-profiles-for-diabetic-nephropathy-in-type-2-diabetes 2026-07-20T07:47:25.000Z daily 0.75 https://www.medxy.ai/news/zh/igg-n-glycosylation-for-diabetic-nephropathy-in-type-2-diabetes 2026-07-20T07:47:42.000Z daily 0.75 https://www.medxy.ai/news/unraveling-rohhad-net-syndrome-clinical-insights-and-the-role-of-anti-zscan1-antibodies-in-diagnosis-and-management 2026-07-19T09:27:13.000Z daily 0.75 https://www.medxy.ai/news/vi/rohhad-net-syndrome-and-anti-zscan1-antibodies-in-diagnosis-and-management 2026-07-20T07:48:19.000Z daily 0.75 https://www.medxy.ai/news/ja/rohhad-net-syndrome-and-anti-zscan1-antibodies 2026-07-20T07:48:48.000Z daily 0.75 https://www.medxy.ai/news/zh/anti-zscan1-antibodies-in-diagnosis-and-management-for-rohhad-net-syndrome 2026-07-20T07:49:15.000Z daily 0.75 https://www.medxy.ai/news/relationship-between-participant-reported-outcomes-residual-beta-cell-function-and-metabolic-parameters-in-youth-with-newly-diagnosed-type-1-diabetes 2026-07-20T07:31:10.000Z daily 0.75 https://www.medxy.ai/news/vi/participant-reported-outcomes-residual-beta-cell-function-and-metabolic-parameters-in-youth-with-newly-diagnosed-t1dm 2026-07-20T07:49:38.000Z daily 0.75 https://www.medxy.ai/news/ja/participant-reported-outcomes-residual-beta-cell-function-in-youth-with-newly-diagnosed-t1dm 2026-07-20T07:49:58.000Z daily 0.75 https://www.medxy.ai/news/comparative-effectiveness-and-safety-of-emerging-myasthenia-gravis-therapies-insights-from-a-bayesian-network-meta-analysis 2026-07-20T07:33:39.000Z daily 0.75 https://www.medxy.ai/news/vi/comparative-effectiveness-and-safety-of-emerging-myasthenia-gravis-therapies 2026-07-20T07:50:36.000Z daily 0.75 https://www.medxy.ai/news/zh/effectiveness-and-safety-of-emerging-myasthenia-gravis-therapies 2026-07-20T07:51:01.000Z daily 0.75 https://www.medxy.ai/news/familial-microvascular-traits-and-neuropsychiatric-factors-reflected-in-brain-perivascular-space-morphometry 2026-07-20T07:46:35.000Z daily 0.75 https://www.medxy.ai/news/vi/familial-microvascular-traits-and-neuropsychiatric-factors-in-brain-perivascular-space-morphometry 2026-07-20T09:12:40.000Z daily 0.75 https://www.medxy.ai/news/ja/microvascular-traits-and-neuropsychiatric-factors-in-brain-perivascular-space-morphometry 2026-07-20T09:13:07.000Z daily 0.75 https://www.medxy.ai/news/zh/brain-perivascular-space-morphometry-on-microvascular-traits-and-neuropsychiatric-factors 2026-07-20T09:13:25.000Z daily 0.75 https://www.medxy.ai/news/dr5-ligase-3-feedback-loop-unlocking-the-immunogenicity-of-mismatch-repair-deficient-colorectal-cancer 2026-07-20T09:13:37.000Z daily 0.75 https://www.medxy.ai/news/targeting-the-il-17-ngal-nets-itga5-axis-a-novel-strategy-to-overcome-immunosuppression-and-fibroblast-reprogramming-in-pancreatic-cancer 2026-07-20T09:13:39.000Z daily 0.75 https://www.medxy.ai/news/vi/targeting-the-il-17-ngal-nets-itga5-axis-in-pancreatic-cancer 2026-07-20T09:48:20.000Z daily 0.75 https://www.medxy.ai/news/zh/il-17-ngal-nets-itga5-axis-overcome-in-pancreatic-cancer 2026-07-20T09:48:49.000Z daily 0.75 https://www.medxy.ai/news/vi/decompensated-cirrhosis-in-mdsld 2026-07-20T09:58:20.000Z daily 0.75 https://www.medxy.ai/news/ja/decompensated-cirrhosis-in-metabolic-dysfunction-related-steatotic-liver-disease 2026-07-20T09:58:01.000Z daily 0.75 https://www.medxy.ai/news/zh/60027-2 2026-07-20T09:55:27.000Z daily 0.75 https://www.medxy.ai/news/child-neurodevelopmental-outcomes-after-late-preterm-hypoglycemia 2026-07-20T09:58:40.000Z daily 0.75 https://www.medxy.ai/news/vi/child-neurodevelopmental-outcomes-in-late-preterm-hypoglycemia 2026-07-20T10:00:19.000Z daily 0.75 https://www.medxy.ai/news/ja/neurodevelopmental-outcomes-in-late-preterm-hypoglycemia 2026-07-20T10:01:01.000Z daily 0.75 https://www.medxy.ai/news/safety-and-long-term-benefits-of-hormone-therapy-after-chemoradiation-in-young-cervical-cancer-survivors 2026-07-20T10:01:17.000Z daily 0.75 https://www.medxy.ai/news/vi/safety-and-long-term-benefits-of-hormone-therapy-after-chemoradiation-in-young-cervical-cancer 2026-07-20T10:17:22.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-benefits-of-hormone-therapy-after-chemoradiation-in-young-cervical-cancer 2026-07-20T10:17:44.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-benefits-of-hormone-therapy-in-young-cervical-cancer 2026-07-20T10:18:08.000Z daily 0.75 https://www.medxy.ai/news/decoding-placental-pathology-risks-in-dichorionic-twins-ultrasound-phenotypes-of-fetal-growth-impairment 2026-07-20T10:16:09.000Z daily 0.75 https://www.medxy.ai/news/vi/placental-pathology-risks-in-dichorionic-twins-of-fetal-growth-impairment 2026-07-20T10:28:43.000Z daily 0.75 https://www.medxy.ai/news/ja/placental-pathology-risks-in-dichorionic-twins 2026-07-20T10:29:13.000Z daily 0.75 https://www.medxy.ai/news/zh/decoding-placental-pathology-risks-in-dichorionic-twins-in-ultrasound-phenotypes 2026-07-20T10:29:46.000Z daily 0.75 https://www.medxy.ai/news/unraveling-failure-to-rescue-in-major-gynecologic-cancer-surgery-insights-from-a-nsqip-analysis 2026-07-20T10:27:54.000Z daily 0.75 https://www.medxy.ai/news/health-insurance-instability-following-firearm-injury-a-matched-cohort-case-report 2026-07-20T10:30:08.000Z daily 0.75 https://www.medxy.ai/news/perioperative-toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc-insights-from-the-neotorch-trial 2026-07-20T10:34:32.000Z daily 0.75 https://www.medxy.ai/news/vi/perioperative-toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc 2026-07-20T10:43:34.000Z daily 0.75 https://www.medxy.ai/news/ja/perioperative-toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc-2 2026-07-20T10:44:18.000Z daily 0.75 https://www.medxy.ai/news/zh/toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc 2026-07-20T10:45:36.000Z daily 0.75 https://www.medxy.ai/news/improving-quality-of-life-with-venting-gastrostomy-tubes-in-malignant-bowel-obstruction-insights-from-a-retrospective-cohort-study 2026-07-20T10:45:52.000Z daily 0.75 https://www.medxy.ai/news/vi/improving-quality-of-life-with-venting-gastrostomy-tubes-in-malignant-bowel-obstruction 2026-07-20T10:53:52.000Z daily 0.75 https://www.medxy.ai/news/ja/quality-of-life-with-venting-gastrostomy-tubes-in-malignant-bowel-obstruction 2026-07-20T10:54:13.000Z daily 0.75 https://www.medxy.ai/news/zh/quality-of-life-in-malignant-bowel-obstruction 2026-07-20T10:54:42.000Z daily 0.75 https://www.medxy.ai/news/long-term-outcomes-of-endoscopic-choanal-atresia-repair-using-mucoperiosteal-flaps-without-stenting-insights-from-a-10-year-pediatric-cohort 2026-07-20T10:55:03.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-outcomes-of-endoscopic-choanal-atresia-repair-using-mucoperiosteal-flaps-without-stenting 2026-07-20T10:55:22.000Z daily 0.75 https://www.medxy.ai/news/ja/outcomes-of-endoscopic-choanal-atresia-repair-using-mucoperiosteal-flaps 2026-07-20T10:55:51.000Z daily 0.75 https://www.medxy.ai/news/zh/outcomes-of-endoscopic-choanal-atresia-repair 2026-07-20T10:56:28.000Z daily 0.75 https://www.medxy.ai/news/how-to-evaluate-a-sinonasal-mass-key-recommendations-from-a-multidisciplinary-consensus 2026-07-20T10:56:41.000Z daily 0.75 https://www.medxy.ai/news/zh/%E5%A6%82%E4%BD%95%E8%AF%84%E4%BC%B0%E9%BC%BB%E7%AA%A6%E9%BC%BB%E8%85%94%E5%8D%A0%E4%BD%8D%EF%BC%9A%E5%A4%9A%E5%AD%A6%E7%A7%91%E5%85%B1%E8%AF%86%E7%9A%84%E5%85%B3%E9%94%AE%E5%BB%BA%E8%AE%AE 2026-07-20T10:58:07.000Z daily 0.75 https://www.medxy.ai/news/vi/danh-gia-khoi-vung-mui-xoang-nhu-the-nao-nhung-khuyen-nghi-trong-tam-tu-dong-thuan-da-chuyen-nganh 2026-07-20T10:58:38.000Z daily 0.75 https://www.medxy.ai/news/ja/%E9%BC%BB%E5%89%AF%E9%BC%BB%E8%85%94%E8%85%AB%E7%98%A4%E3%82%92%E3%81%A9%E3%81%86%E8%A9%95%E4%BE%A1%E3%81%99%E3%82%8B%E3%81%8B%EF%BC%9A%E5%AD%A6%E9%9A%9B%E7%9A%84%E3%82%B3%E3%83%B3%E3%82%BB%E3%83%B3 2026-07-20T10:59:11.000Z daily 0.75 https://www.medxy.ai/news/assessing-the-risk-of-cns-demyelination-associated-with-tnf-%CE%B1-inhibitors-insights-from-a-large-us-health-network 2026-07-20T12:44:08.000Z daily 0.75 https://www.medxy.ai/news/vi/danh-gia-nguy-co-mat-myelin-he-than-kinh-trung-uong-lien-quan-den-chat-uc-che-tnf-%CE%B1-goc-nhin-tu-mot-mang-luoi-y-te-quy-mo-lon-tai-hoa-ky 2026-07-20T12:44:56.000Z daily 0.75 https://www.medxy.ai/news/ja/tnf-%CE%B1%E9%98%BB%E5%AE%B3%E8%96%AC%E3%81%A8%E4%B8%AD%E6%9E%A2%E7%A5%9E%E7%B5%8C%E7%B3%BB%E8%84%B1%E9%AB%84%E3%83%AA%E3%82%B9%E3%82%AF%E3%82%92%E6%A4%9C%E8%A8%BC%EF%BC%9A%E7%B1%B3%E5%9B%BD%E5%A4%A7 2026-07-20T12:45:16.000Z daily 0.75 https://www.medxy.ai/news/zh/tnf-%CE%B1%E6%8A%91%E5%88%B6%E5%89%82%E4%B8%8E%E4%B8%AD%E6%9E%A2%E7%A5%9E%E7%BB%8F%E7%B3%BB%E7%BB%9F%E8%84%B1%E9%AB%93%E9%9E%98%E9%A3%8E%E9%99%A9%EF%BC%9A%E6%9D%A5%E8%87%AA%E7%BE%8E%E5%9B%BD%E5%A4%A7 2026-07-20T12:45:34.000Z daily 0.75 https://www.medxy.ai/news/comparative-diagnostic-accuracy-of-retinal-birefringence-scanning-vs-traditional-autorefraction-in-pediatric-vision-screening 2026-07-20T13:12:53.000Z daily 0.75 https://www.medxy.ai/news/vi/diagnostic-accuracy-of-retinal-birefringence-scanning-vs-traditional-autorefraction-in-pediatric-vision-screening 2026-07-20T13:52:29.000Z daily 0.75 https://www.medxy.ai/news/increased-risk-of-dry-eye-disease-in-patients-with-chronic-pain-conditions-insights-from-a-large-retrospective-cohort-study 2026-07-20T13:46:27.000Z daily 0.75 https://www.medxy.ai/news/ja/increased-risk-of-dry-eye-disease-in-patients-with-chronic-pain-conditions 2026-07-20T13:53:04.000Z daily 0.75 https://www.medxy.ai/news/zh/risk-of-dry-eye-disease-in-patients-with-chronic-pain-conditions 2026-07-20T13:53:19.000Z daily 0.75 https://www.medxy.ai/news/unveiling-the-roles-of-mast-cells-and-endothelial-cells-in-il-33-st2-pathway-dysregulation-in-copd-lungs 2026-07-20T13:51:10.000Z daily 0.75 https://www.medxy.ai/news/vi/the-roles-of-mast-cells-and-endothelial-cells-in-il-33-st2-pathway-dysregulation-in-copd-lungs 2026-07-20T13:53:48.000Z daily 0.75 https://www.medxy.ai/news/ja/mast-cells-and-endothelial-cells-in-il-33-st2-pathway-dysregulation-in-copd-lungs 2026-07-20T13:54:07.000Z daily 0.75 https://www.medxy.ai/news/zh/mast-cells-and-endothelial-cells-in-il-33-st2-pathway-in-copd-lungs 2026-07-20T13:54:26.000Z daily 0.75 https://www.medxy.ai/news/real-world-effectiveness-of-adjuvanted-rsvpref3-vaccine-in-preventing-rsv-related-hospitalization-among-us-adults-aged-%E2%89%A560-years-a-comprehensive-review 2026-07-20T22:25:00.000Z daily 0.75 https://www.medxy.ai/news/vi/effectiveness-of-adjuvanted-rsvpref3-vaccine-in-preventing-rsv-related-hospitalization-among-us-adults-aged-%E2%89%A560-years 2026-07-20T22:25:33.000Z daily 0.75 https://www.medxy.ai/news/ja/effectiveness-of-adjuvanted-rsvpref3-vaccine-in-rsv-related-hospitalization-among-us-adults-aged-%E2%89%A560-years 2026-07-20T22:26:19.000Z daily 0.75 https://www.medxy.ai/news/blinatumomab-consolidation-in-high-risk-ph-negative-b-cell-acute-lymphoblastic-leukemia-insights-from-the-graall-2014-b-quest-study 2026-07-20T22:24:43.000Z daily 0.75 https://www.medxy.ai/news/vi/blinatumomab-consolidation-in-high-risk-ph-negative-b-cell-acute-lymphoblastic-leukemia 2026-07-20T22:34:58.000Z daily 0.75 https://www.medxy.ai/news/ja/blinatumomab-consolidation-in-high-risk-ph-negative-b-cell-all 2026-07-20T22:35:04.000Z daily 0.75 https://www.medxy.ai/news/zh/blinatumomab-in-high-risk-ph-negative-b-cell-all 2026-07-20T22:34:40.000Z daily 0.75 https://www.medxy.ai/news/measurable-residual-disease-as-a-prognostic-biomarker-in-frontline-azacitidine-and-venetoclax-treated-aml-insights-from-the-french-venaura-registry 2026-07-20T22:27:51.000Z daily 0.75 https://www.medxy.ai/news/vi/measurable-residual-disease-as-a-prognostic-biomarker-in-frontline-azacitidine-and-venetoclax-treated-aml 2026-07-20T22:35:31.000Z daily 0.75 https://www.medxy.ai/news/ja/mrd-as-a-prognostic-biomarker-in-frontline-azacitidine-and-venetoclax-treated-aml 2026-07-20T22:35:55.000Z daily 0.75 https://www.medxy.ai/news/zh/mrd-as-a-prognostic-biomarker-in-azacitidine-and-venetoclax-treated-aml 2026-07-20T22:36:34.000Z daily 0.75 https://www.medxy.ai/news/acp-calls-for-overhaul-of-u-s-dietary-supplement-rules-key-recommendations-from-the-2026-position-paper 2026-07-21T06:31:01.000Z daily 0.75 https://www.medxy.ai/news/zh/acp-calls-for-overhaul-of-u-s-dietary-supplement-rules 2026-07-21T06:36:15.000Z daily 0.75 https://www.medxy.ai/news/vi/acp-calls-of-u-s-dietary-supplement-rules 2026-07-21T06:36:31.000Z daily 0.75 https://www.medxy.ai/news/ja/acp-calls-of-us-dietary-supplement-rules 2026-07-21T06:36:46.000Z daily 0.75 https://www.medxy.ai/news/correlation-between-physicians-clinical-knowledge-and-reduction-of-low-value-services-in-older-adults 2026-07-21T06:40:24.000Z daily 0.75 https://www.medxy.ai/news/vi/physicians-clinical-knowledge-and-reduction-of-low-value-services-in-older-adults 2026-07-21T09:33:46.000Z daily 0.75 https://www.medxy.ai/news/ja/physicians-clinical-knowledge-in-older-adults 2026-07-21T09:34:11.000Z daily 0.75 https://www.medxy.ai/news/zh/physicians-clinical-knowledge-and-reduction-of-low-value-services 2026-07-21T09:34:26.000Z daily 0.75 https://www.medxy.ai/news/predicting-opioid-use-disorder-and-overdose-risk-in-older-adults-evaluating-prognostic-models 2026-07-21T09:06:40.000Z daily 0.75 https://www.medxy.ai/news/vi/predicting-opioid-use-disorder-and-overdose-risk-in-older-adults 2026-07-21T09:34:42.000Z daily 0.75 https://www.medxy.ai/news/ja/opioid-use-disorder-and-overdose-risk-in-older-adults-evaluating-prognostic-models 2026-07-21T09:34:56.000Z daily 0.75 https://www.medxy.ai/news/zh/opioid-use-disorder-and-overdose-risk-in-older-adults 2026-07-21T09:35:08.000Z daily 0.75 https://www.medxy.ai/news/awake-intubation-in-emergency-settings-incidence-techniques-and-outcomes-from-a-decade-of-airway-registries 2026-07-21T09:31:16.000Z daily 0.75 https://www.medxy.ai/news/vi/awake-intubation-in-emergency-settings-incidence-techniques-and-outcomes 2026-07-21T09:35:25.000Z daily 0.75 https://www.medxy.ai/news/ja/awake-intubation-in-emergency-settings 2026-07-21T09:36:05.000Z daily 0.75 https://www.medxy.ai/news/zh/awake-intubation-in-emergency 2026-07-21T09:36:19.000Z daily 0.75 https://www.medxy.ai/news/enhancing-decannulation-success-in-neurologic-patients-the-role-of-abdominal-electrical-stimulation-combined-with-airway-clearance-techniques 2026-07-21T09:36:43.000Z daily 0.75 https://www.medxy.ai/news/vi/enhancing-decannulation-success-in-neurologic-patients-the-role-of-abdominal-electrical-stimulation 2026-07-21T09:39:13.000Z daily 0.75 https://www.medxy.ai/news/ja/decannulation-success-in-neurologic-patients-the-role-of-abdominal-electrical-stimulation 2026-07-21T09:39:50.000Z daily 0.75 https://www.medxy.ai/news/zh/decannulation-success-in-neurologic-patients-with-abdominal-electrical-stimulation 2026-07-21T09:40:11.000Z daily 0.75 https://www.medxy.ai/news/combining-tissue-hypoperfusion-markers-with-vasopressor-dose-enhances-mortality-risk-stratification-in-refractory-septic-shock 2026-07-21T09:38:50.000Z daily 0.75 https://www.medxy.ai/news/vi/tissue-hypoperfusion-markers-with-vasopressor-dose-enhances-mortality-risk-stratification-in-refractory-septic-shock 2026-07-21T09:40:38.000Z daily 0.75 https://www.medxy.ai/news/ja/tissue-hypoperfusion-markers-with-vasopressor-dose-in-refractory-septic-shock 2026-07-21T09:41:32.000Z daily 0.75 https://www.medxy.ai/news/zh/tissue-hypoperfusion-with-vasopressor-in-refractory-septic-shock 2026-07-21T09:41:47.000Z daily 0.75 https://www.medxy.ai/news/mapping-2-year-psychiatric-and-neurologic-risks-after-infections-across-body-systems-and-age-groups-an-integrative-review 2026-07-21T13:48:26.000Z daily 0.75 https://www.medxy.ai/news/vi/mapping-2-year-psychiatric-and-neurologic-risks-after-infections-across-body-systems-and-age-groups 2026-07-21T13:48:19.000Z daily 0.75 https://www.medxy.ai/news/ja/2-year-psychiatric-and-neurologic-risks-after-infections-across-body-systems-and-age-groups 2026-07-21T13:48:45.000Z daily 0.75 https://www.medxy.ai/news/zh/2-year-psychiatric-and-neurologic-risks-after-infections 2026-07-21T13:50:11.000Z daily 0.75 https://www.medxy.ai/news/clarifying-dorsal-preservation-rhinoplasty-insights-and-classification-from-over-a-thousand-cases 2026-07-21T11:04:21.000Z daily 0.75 https://www.medxy.ai/news/vi/dorsal-preservation-rhinoplasty-insights-and-classification-from-over-a-thousand-cases 2026-07-21T13:50:54.000Z daily 0.75 https://www.medxy.ai/news/ja/dorsal-preservation-rhinoplasty 2026-07-21T13:51:12.000Z daily 0.75 https://www.medxy.ai/news/zh/dorsal-preservation-rhinoplasty-2 2026-07-21T13:51:33.000Z daily 0.75 https://www.medxy.ai/news/what-lies-beneath-navigating-carotid-artery-depth-for-safe-hemostatic-net-use-in-facelift-surgery 2026-07-21T13:47:46.000Z daily 0.75 https://www.medxy.ai/news/vi/navigating-carotid-artery-depth-for-safe-hemostatic-net-use-in-facelift-surgery 2026-07-21T13:51:52.000Z daily 0.75 https://www.medxy.ai/news/ja/carotid-artery-depth-for-safe-hemostatic-net-use-in-facelift-surgery 2026-07-21T13:52:14.000Z daily 0.75 https://www.medxy.ai/news/zh/carotid-artery-depth-for-safe-hemostatic-net-use-in-surgery 2026-07-21T13:52:29.000Z daily 0.75 https://www.medxy.ai/news/digital-standardized-skin-care-regimen-enhances-outcomes-in-patients-with-acne-rosacea-comorbidity-insights-from-a-real-world-longitudinal-cohort 2026-07-21T13:54:42.000Z daily 0.75 https://www.medxy.ai/news/vi/digital-standardized-skin-care-regimen-enhances-outcomes-in-patients-with-acne-rosacea-comorbidity 2026-07-21T13:58:23.000Z daily 0.75 https://www.medxy.ai/news/ja/digital-standardized-skin-care-regimen-enhances-outcomes-in-patients-with-acne-rosacea 2026-07-21T13:58:55.000Z daily 0.75 https://www.medxy.ai/news/zh/digital-standardized-skin-care-enhances-outcomes-in-patients-with-acne-rosacea-comorbidity 2026-07-21T13:59:12.000Z daily 0.75 https://www.medxy.ai/news/impact-of-medically-tailored-groceries-on-glycemic-control-in-medicaid-insured-adults-with-type-2-diabetes-insights-from-a-randomized-controlled-trial 2026-07-21T14:13:21.000Z daily 0.75 https://www.medxy.ai/news/vi/medically-tailored-groceries-on-glycemic-control-in-medicaid-insured-adults-with-type-2-diabetes 2026-07-21T14:18:37.000Z daily 0.75 https://www.medxy.ai/news/ja/medically-tailored-groceries-on-glycemic-control-in-adults-with-type-2-diabetes 2026-07-21T14:18:55.000Z daily 0.75 https://www.medxy.ai/news/zh/medically-tailored-groceries-on-glycemic-control-in-adults-with-t2dm 2026-07-21T14:19:07.000Z daily 0.75 https://www.medxy.ai/news/long-term-exposure-to-pm2-5-constituents-and-coronary-heart-disease-risk-in-china-a-comprehensive-review 2026-07-21T14:19:42.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-exposure-to-pm2-5-constituents-and-coronary-heart-disease-risk 2026-07-21T22:30:59.000Z daily 0.75 https://www.medxy.ai/news/ja/exposure-to-pm2-5-constituents-and-coronary-heart-disease-risk 2026-07-21T22:31:22.000Z daily 0.75 https://www.medxy.ai/news/zh/exposure-to-pm2-5-constituents-and-chd-risk 2026-07-21T22:31:38.000Z daily 0.75 https://www.medxy.ai/news/glp-1-receptor-agonists-a-breakthrough-in-reducing-atherosclerosis-and-cardiovascular-risk-beyond-diabetes-and-obesity 2026-07-22T07:42:08.000Z daily 0.75 https://www.medxy.ai/news/ja/glp-1-receptor-agonists-a-breakthrough-in-reducing-atherosclerosis-and-cardiovascular-risk 2026-07-22T08:54:03.000Z daily 0.75 https://www.medxy.ai/news/bmi-normalization-significantly-reduces-risk-of-type-1-diabetes-progression-in-youth 2026-07-22T10:50:50.000Z daily 0.75 https://www.medxy.ai/news/vi/bmi-normalization-significantly-reduces-risk-of-t1dm 2026-07-22T13:30:24.000Z daily 0.75 https://www.medxy.ai/news/ja/bmi-normalization-reduces-risk-of-t1dm 2026-07-22T13:30:40.000Z daily 0.75 https://www.medxy.ai/news/zh/bmi-normalization-reduces-risk-of-t1dm-2 2026-07-22T13:30:52.000Z daily 0.75 https://www.medxy.ai/news/oral-semaglutide-and-cardiovascular-benefits-in-the-soul-trial-impact-of-baseline-and-changes-in-hba1c-and-bmi-on-clinical-outcomes 2026-07-22T13:27:06.000Z daily 0.75 https://www.medxy.ai/news/vi/oral-semaglutide-and-cardiovascular-benefits-in-the-soul-trial 2026-07-22T16:06:40.000Z daily 0.75 https://www.medxy.ai/news/ja/oral-semaglutide-and-cardiovascular-benefits 2026-07-22T16:06:57.000Z daily 0.75 https://www.medxy.ai/news/mild-cold-exposure-with-shivering-lowers-24-hour-glucose-levels-in-type-2-diabetes-a-novel-adjunctive-therapy 2026-07-22T16:09:57.000Z daily 0.75 https://www.medxy.ai/news/vi/mild-cold-exposure-with-shivering-lowers-24-hour-glucose-levels-in-type-2-diabetes 2026-07-22T16:11:20.000Z daily 0.75 https://www.medxy.ai/news/ja/mild-cold-exposure-with-shivering-lowers-24-hour-glucose-levels-in-t2dm 2026-07-22T16:11:33.000Z daily 0.75 https://www.medxy.ai/news/zh/mild-cold-with-shivering-lowers-24-hour-glucose-levels-in-t2dm 2026-07-22T16:11:55.000Z daily 0.75 https://www.medxy.ai/news/optimizing-antithyroid-drug-duration-in-graves-disease-with-low-trab-evidence-for-shorter-therapy 2026-07-22T16:12:05.000Z daily 0.75 https://www.medxy.ai/news/vi/optimizing-antithyroid-drug-duration-in-graves-disease-with-low-trab 2026-07-22T16:13:27.000Z daily 0.75 https://www.medxy.ai/news/ja/optimizing-antithyroid-drug-duration-in-graves-disease 2026-07-22T16:14:08.000Z daily 0.75 https://www.medxy.ai/news/zh/antithyroid-drug-duration-in-graves-disease 2026-07-22T16:14:22.000Z daily 0.75 https://www.medxy.ai/news/long-term-road-traffic-noise-exposure-and-its-association-with-parkinson-disease-risk-insights-from-a-danish-nationwide-cohort-study 2026-07-22T16:14:33.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-road-traffic-noise-exposure-and-its-association-with-parkinson-disease-risk 2026-07-23T15:46:17.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-road-traffic-noise-exposure-and-its-association-with-parkinson-disease 2026-07-23T15:47:06.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-road-traffic-noise-exposure-link-parkinson-disease 2026-07-23T15:47:28.000Z daily 0.75 https://www.medxy.ai/news/international-consensus-on-measuring-and-repairing-the-gut-barrier-in-ibd-practical-guidance-for-clinical-trials 2026-07-23T16:13:04.000Z daily 0.75 https://www.medxy.ai/news/endothelial-to-mesenchymal-transition-for-portal-vein-thrombosis-in-cirrhosis 2026-07-23T16:23:08.000Z daily 0.75 https://www.medxy.ai/news/enhanced-prenatal-care-models-in-low-income-latine-populations 2026-07-23T16:34:57.000Z daily 0.75 https://www.medxy.ai/news/assessing-uterine-scar-healing-after-consecutive-cesareans 2026-07-23T16:42:23.000Z daily 0.75 https://www.medxy.ai/news/the-economic-burden-of-gestational-diabetes-and-body-mass-index-changes-between-pregnancies-a-retrospective-cohort-study 2026-07-24T06:51:38.000Z daily 0.75 https://www.medxy.ai/news/vi/the-economic-burden-of-gestational-diabetes-and-body-mass-index-changes-between-pregnancies 2026-07-24T06:49:59.000Z daily 0.75 https://www.medxy.ai/news/ja/the-economic-burden-of-gestational-diabetes-and-body-mass-index-in-pregnancies 2026-07-24T06:51:21.000Z daily 0.75 https://www.medxy.ai/news/comparing-flot-and-cross-protocols-survival-and-recurrence-in-esophageal-adenocarcinoma-with-pathological-complete-response 2026-07-24T09:45:23.000Z daily 0.75 https://www.medxy.ai/news/vi/comparing-flot-and-cross-protocols-survival-and-recurrence-in-esophageal-adenocarcinoma 2026-07-24T09:46:25.000Z daily 0.75 https://www.medxy.ai/news/ja/flot-and-cross-survival-and-recurrence-in-esophageal-adenocarcinoma 2026-07-24T09:39:59.000Z daily 0.75 https://www.medxy.ai/news/zh/flot-and-cross-protocol-in-esophageal-adenocarcinoma 2026-07-24T09:40:15.000Z daily 0.75 https://www.medxy.ai/news/ct-imaging-reveals-critical-laryngotracheal-changes-post-tracheostomy-predictors-of-decannulation-success 2026-07-24T09:48:32.000Z daily 0.75 https://www.medxy.ai/news/hypoglossal-nerve-stimulation-and-cardiovascular-disease-risk-in-obstructive-sleep-apnea-a-comprehensive-review 2026-07-24T09:56:45.000Z daily 0.75 https://www.medxy.ai/news/vi/hypoglossal-nerve-stimulation-and-cardiovascular-disease-risk-in-obstructive-sleep-apnea 2026-07-24T09:56:56.000Z daily 0.75 https://www.medxy.ai/news/ja/hypoglossal-nerve-stimulation-and-cardiovascular-disease-in-obstructive-sleep-apnea 2026-07-24T09:57:19.000Z daily 0.75 https://www.medxy.ai/news/zh/hypoglossal-nerve-stimulation-and-cardiovascular-disease-in-osa 2026-07-24T09:57:57.000Z daily 0.75 https://www.medxy.ai/news/fungal-endophthalmitis-associated-with-contaminated-trypan-blue-in-cataract-surgery-a-retrospective-case-series 2026-07-24T09:58:25.000Z daily 0.75 https://www.medxy.ai/news/enhancing-mutation-detection-in-nsclc-evaluating-concurrent-ebus-tbna-and-liquid-biopsy-ngs-approaches 2026-07-24T10:02:14.000Z daily 0.75 https://www.medxy.ai/news/g3bp2-mediated-venetoclax-resistance-via-elf1-driven-mcl1-transcription-in-acute-myeloid-leukemia-mechanisms-and-therapeutic-implications 2026-07-24T10:22:36.000Z daily 0.75 https://www.medxy.ai/news/vi/g3bp2-mediated-venetoclax-resistance-via-elf1-driven-mcl1-transcription-in-acute-myeloid-leukemia 2026-07-24T10:31:55.000Z daily 0.75 https://www.medxy.ai/news/ja/g3bp2-mediated-venetoclax-resistance-via-elf1-mcl1-in-acute-myeloid-leukemia 2026-07-24T10:32:23.000Z daily 0.75 https://www.medxy.ai/news/zh/g3bp2-mediated-venetoclax-resistance-via-elf1-mcl1-in-aml 2026-07-24T10:32:34.000Z daily 0.75 https://www.medxy.ai/news/bridging-periodontitis-and-clonal-hematopoiesis-implications-for-solid-tumor-metastasis-clinical-trial-design 2026-07-24T10:53:19.000Z daily 0.75 https://www.medxy.ai/news/vi/bridging-periodontitis-and-clonal-hematopoiesis-implications-for-solid-tumor-metastasis 2026-07-24T10:53:32.000Z daily 0.75 https://www.medxy.ai/news/ja/periodontitis-and-clonal-hematopoiesis-implications-for-solid-tumor-metastasis 2026-07-24T10:53:48.000Z daily 0.75 https://www.medxy.ai/news/zh/periodontitis-and-clonal-hematopoiesis-for-solid-tumor-metastasis 2026-07-24T10:54:08.000Z daily 0.75 https://www.medxy.ai/news/olorofim-for-poorly-controlled-disseminated-coccidioidomycosis-phase-2b-clinical-efficacy-and-safety-insights 2026-07-24T10:55:32.000Z daily 0.75 https://www.medxy.ai/news/vi/olorofim-for-poorly-controlled-disseminated-coccidioidomycosis-efficacy-and-safety-insights 2026-07-24T10:55:54.000Z daily 0.75 https://www.medxy.ai/news/ja/olorofim-for-poorly-controlled-disseminated-coccidioidomycosis-efficacy-and-safety 2026-07-24T10:56:09.000Z daily 0.75 https://www.medxy.ai/news/zh/efficacy-and-safety-olorofim-for-poorly-controlled-disseminated-coccidioidomycosis 2026-07-24T12:18:06.000Z daily 0.75 https://www.medxy.ai/news/initiation-adherence-and-persistence-to-guideline-directed-medical-therapy-after-heart-failure-hospitalization 2026-07-24T12:18:26.000Z daily 0.75 https://www.medxy.ai/news/vi/adherence-and-persistence-to-guideline-directed-medical-therapy-after-heart-failure-hospitalization 2026-07-24T12:18:39.000Z daily 0.75 https://www.medxy.ai/news/pluralistic-model-proposed-for-schizophrenia-spectrum-beyond-dopamine 2026-07-25T05:07:47.422Z daily 0.75 https://www.medxy.ai/news/zh/pluralistic-model-for-schizophrenia-spectrum-beyond-dopamine 2026-07-25T04:35:27.927Z daily 0.75 https://www.medxy.ai/news/vi/immediate-lymphatic-reconstruction-cuts-lymphedema-risk-after-axillary-dissection 2026-07-25T05:06:17.094Z daily 0.75 https://www.medxy.ai/news/combined-septal-extension-and-derotation-grafts-provide-superior-long-term-tip-stability-in-rhinoplasty 2026-07-25T21:06:55.049Z daily 0.75 https://www.medxy.ai/news/vi/combined-septal-extension-and-derotation-grafts-lead-superior-long-term-tip-stability-in-rhinoplasty 2026-07-25T21:00:34.842Z daily 0.75 https://www.medxy.ai/news/ssris-vs-second-generation-antipsychotics-for-managing-agitation-in-dementia 2026-07-24T12:30:16.000Z daily 0.75 https://www.medxy.ai/news/optimizing-needle-thoracostomy-in-obese-patients-chest-wall-thickness-influences-on-site-selection-and-needle-length 2026-07-24T12:55:25.000Z daily 0.75